Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases

Victoria Furer*, Christien Rondaan, Nancy Agmon-Levin, Sander Van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette De Thurah, Ulf Mueller-Ladner, Daphna Paran, Karen Schreiber, Klaus Warnatz, Nico M. Wulffraat, Ori Elkayam

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

In view of the COVID-19 pandemic, there is an unmet clinical need for the guidelines on vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). This position paper summarises the current data on COVID-19 infection in patients with AIIRD and development of vaccines against COVID-19, discusses the aspects of efficacy and safety of vaccination, and proposes preliminary considerations on vaccination against COVID-19 in patients with AIIRD, mainly based on the expert opinion and knowledge on the use of other vaccines in this population of patients.

Original languageEnglish
Article numbere001594
JournalRMD Open
Volume7
Issue number1
DOIs
StatePublished - 24 Feb 2021

Keywords

  • COVID-19
  • autoimmune diseases
  • vaccination

Fingerprint

Dive into the research topics of 'Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases'. Together they form a unique fingerprint.

Cite this